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ABSTRACT Fast Ca21 release kinetics were measured in cardiac sarcoplasmic reticulum vesicles actively loaded with Ca21.
Release was induced in solutions containing 1.2 mM free ATP and variable free [Ca21] and [Mg21]. Release rate constants (k)
were 10-fold higher at pCa 6 than at pCa 5 whereas Ryanodine binding was highest at pCa #5. These results suggest that
channels respond differently when exposed to sudden [Ca21] changes than when exposed to Ca21 for longer periods. Vesicles
with severalfold different luminal calcium contents exhibited double exponential release kinetics at pCa 6, suggesting that
channels undergo time-dependent activity changes. Addition of Mg21 produced a marked inhibition of release kinetics at pCa 6
(K0.5 ¼ 63 mM) but not at pCa 5. Coexistence of calcium activation and inhibition sites with equally fast binding kinetics is
proposed to explain this behavior. Thimerosal activated release kinetics at pCa 5 at all [Mg21] tested and increased at pCa 6 the
K0.5 for Mg
21 inhibition, from 63 mM to 136 mM. We discuss the possible relevance of these results, which suggest release
through RyR2 channels is subject to fast regulation by Ca21 and Mg21 followed by time-dependent regulation, to the
physiological mechanisms of cardiac channel opening and closing.
INTRODUCTION
During each cardiac action potential, a small Ca21 inﬂux
through plasma membranes L-type channels initiates the
intracellular free [Ca21] increase responsible for the cyclic
contractions of mammalian cardiac muscle. The resulting
local increase in free [Ca21] activates subplasmalemmal
sarcoplasmic reticulum (SR) Ca21-release channels, which,
through Ca21-induced Ca21 release (CICR), increase
cytoplasmic free [Ca21] to the levels required for contraction
(Bers, 2001, 2002). The cytosolic Ca21 transient reﬂects the
concerted activation of many cardiac speciﬁc isoforms of the
Ryanodine receptor (RyR) release channels (Otsu et al.,
1990; Witcher et al., 1991). Due to their central role in
cardiac excitation contraction coupling, the regulation of
cardiac release channels (RyR2 channels) has been a matter
of extensive investigation (reviewed in Coronado et al.,
1994; Zucchi and Ronca-Testoni, 1997). Yet, important
questions regarding the regulation of RyR2 channels, such
as the physiological mechanisms responsible for channel
closing during each cardiac contraction/relaxation cycle,
remain unresolved.
By measuring intracellular Ca21 transients, it has been
possible to analyze the response of groups of RyR2 channels
in whole cardiac cells (Beuckelmann and Wier, 1988; Blatter
et al., 1997). However, cellular regulatory mechanisms do
not permit induction of well-deﬁned changes in ionic
concentrations (Ca21, Mg21), pH, or channel redox status
that modify channel activity in vitro. Studies of fast
(milliseconds) Ca21 release ﬂuxes using stopped ﬂow optical
techniques has advanced current understanding of the
regulation of the skeletal RyR1 channel isoforms. These
studies have provided information on how transverse tubule
depolarization, Ca21, Mg21, and redox state affect channel
function (Ikemoto et al., 1994; Yamaguchi et al., 1997;
Donoso et al., 2000). In contrast, there are few reports of
RyR2-mediated fast Ca21 release ﬂuxes determined with
stopped ﬂow optical techniques (Yano et al., 1998; Ono et al.,
2000). The properties of RyR2 channels have been analyzed
in vitro using methods that lack the ms time resolution of
optical techniques. These methods include assessing [3H]-
Ryanodine binding (Xu et al., 1996; Liu et al., 1998; Fruen
et al., 2000), characterizing single channel activity in bilayers
(Laver et al., 1995, 1997; Du et al, 2001), or measuring Ca21
release ﬂuxes with other procedures (Meissner et al., 1986;
Rousseau et al., 1986; Xu et al., 1996; Fruen et al., 2000).
Measurements with ms temporal resolution are likely to
better reﬂect the physiological response of RyR2 channels to
the sudden [Ca21] changes that occur during cardiac channel
activation (Bers, 2001, 2002). Stopped ﬂow systems allow
mixing vesicles with releasing solutions in less than 2 ms,
and yield data with high temporal resolution because records
are collected with several hundred data points. Determina-
tions of fast Ca21 release ﬂuxes have the additional ad-
vantage that the rate constant of Ca21 release correlates with
average open probability and conductance of the releasing
channels (Miller, 1984; Donoso et al., 1995; Me´sza´ros et al.,
1998). For these reasons, in this study we measured fast
Ca21 release ﬂuxes to characterize how the RyR2 channel
population present in cardiac SR vesicles responds in
different conditions to sudden [Ca21] changes. Our results
show maximal activation of release kinetics at pCa 6 in the
absence of free [Mg21], with release rate constants as high as
110 s1, whereas maximal activation of [3H]-Ryanodine
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binding required pCa #5. Furthermore, at pCa 6, Ca21
release exhibited double exponential kinetics, regardless of
variations in luminal calcium content from \10 nmol/mg
protein to 80 nmol/mg protein. These results suggest that the
double exponential behavior is not due to a decrease in
luminal calcium content but probably reﬂects an intrinsic
time-dependent decrease in cardiac release channel activity
after activation. Addition of up to 0.8 mM free [Mg21] did
not modify release kinetics at pCa 5 but markedly inhibited
release rate constants at pCa 6, with K0.5 ¼ 63 mM. Caffeine
(6 mM) reversed the inhibition exerted by 0.3 mM free
[Mg21] at pCa 6. Addition of thimerosal activated release
kinetics reversibly at pCa 5, but had a modest effect on
channel inhibition by Mg21 at pCa 6.
We discuss the possible relevance of these results,
including modulation of channel activity by redox modiﬁ-
cation, to the physiological mechanisms that underlie RyR2
channel opening and closing.
MATERIALS AND METHODS
Isolation of SR vesicles
Sarcoplasmic reticulum vesicles were isolated from canine hearts following
a modiﬁcation of previous methods (Inui et al., 1988). All procedures were
done according to the ‘‘Position of the American Heart Association on
Research and Animal Use’’ and the guidelines of the Animal Care
Committee of the Faculty of Medicine, University of Chile. Brieﬂy, dogs of
either sex weighing 12–16 kg were anaesthetized with pentobarbital. The
hearts were quickly removed and perfused through the aorta with a cold
cardioplegic solution (in mM): 2 CaCl2, 16 MgCl2, 102 NaCl, 20 KCl, 2
EGTA, 20 MOPS adjusted with Tris base to pH 6.8. All the following
procedures were carried out at 48C. The left ventricle was ﬁnely minced and
homogenized in four volumes of ice-cold homogenization buffer. This
solution contained (in mM): 300 sucrose, 20 MOPS adjusted with Tris base
to pH 6.8, and a combination of protease inhibitors (4 mg/ml Leupeptin,
4 mg/ml Pepstatin A, 1 mM Benzamidine, 1 mM phenylmethylsulfonyl
ﬂuoride). Tissues were homogenized in a Heidolph Diax 600 homogenizer
using three 15 s bursts at 24,000 rpm followed each time by 5 s rest intervals.
The homogenate was sedimented at 3800 3 g for 15 min and the resulting
pellet was homogenized in three volumes of homogenization buffer as
above, and sedimented at 3800 3 g for 15 min. The combined supernatants
were ﬁltered through cheesecloth and were sedimented at 28,0003 g for 15
min. Solid KCl was added to the supernatant to a ﬁnal concentration of 0.65
M before centrifugation at 120,000 3 g for 1 h. The pellet, enriched in SR
vesicles, was resuspended in homogenization buffer to a ﬁnal protein
concentration of 10 mg per ml, fractionated in small aliquots and snap-
frozen in liquid N2. Vesicles were stored at 808C for up to 2–3 weeks.
Active loading of cardiac SR vesicles with calcium
SR vesicles (1 mg/ml) were added to a solution containing (in mM): 0.05
CaCl2, 100 KCl, 10 phosphocreatine, 15 U/ml creatine kinase, 20 imidazole-
MOPS, pH 7.2, and 0.1 mM Calcium Green 2 or Calcium Green 5N.
Calcium uptake was determined at 258C by measuring extravesicular free
[Ca21] changes in a ﬂuorescence spectrophotometer (JOBIN YVON-SPEX
FluoroMax-2). Uptake, initiated by adding a small volume of Mg-ATP
(2 mM ATP, 3 mM MgCl2) was completed in\20 min. After cessation of
uptake, vesicles retained the accumulated Ca21 for periods $30 min. To
assess the effect of intravesicular Ca21 load on Ca21 release, vesicles were
actively loaded in three different conditions: with no CaCl2 added, with 50
mM CaCl2 or with 100 mM CaCl2. The average free [Ca
21] of uptake
solutions with no added CaCl2 was 5 mM, and increased to 9 mM after
addition of 1 mg/ml SR vesicles, as determined by measuring the free [Ca21]
of the ﬁltrate as described below, using Calcium Green 5N (Kd¼ 27.5 mM).
To assess the calcium content acquired by SR vesicles after active loading,
vesicles were incubated as above, except that solutions contained 45CaCl2
(speciﬁc activity 0.5 mCi/mmol). Vesicular calcium was determined by
manual ﬁltration through Millipore ﬁlters (AA 0.8 mm), as described in
detail previously (Donoso et al., 2000). Vesicles (1 mg/ml) incubated
in solutions with 50 mM or 100 mM free [Ca21] displayed signiﬁcant
nonspeciﬁc calcium binding, which amounted to 25% of the total amount of
calcium actively accumulated. To determine the free [Ca21] remaining in the
uptake solution after cessation of uptake, vesicles (1 mg/ml) were removed
from the solution by manual ﬁltration through MFS-25 ﬁlters (0.20 mm,
Advantec MFS, Pleasanton, CA). The free [Ca21] of the ﬁltrate was
determined ﬂuorometrically with Calcium Green 2 (Kd ¼ 0.44 mM).
Calcium release kinetics
To follow Ca21 release kinetics, a SX.18MV ﬂuorescence stopped-ﬂow
spectrometer from Applied Photophysics Ltd. (Leatherhead, UK) was used.
The increase in extravesicular [Ca21] was determined with different
ﬂuorescent Ca21 indicators. Fluo 3 was used in the pCa range 6.9–6.3,
Calcium Green 2 at pCa 6.3–6, and Calcium Green 5N in the pCa range
6–4.8. Whenever possible, two indicators with differentKd values were used
for a given pCa value. Dye ﬂuorescent emission was measured through
a 515-nm cutoff long-pass ﬁlter, using an excitation wavelength of 488 nm.
Calcium release was initiated by mixing 10 volumes of releasing solution
with 1 volume of a solution containing Ca21-loaded SR vesicles. Releasing
solutions were designed to generate after mixing a constant free [ATP] of 1.2
mM and different free [Ca21] to cover the pCa range 6.9–4.8. Higher free
[Ca21] were not investigated because the signal generated by the released
Ca21 was obscured when the free [Ca21] of the releasing solution was $15
mM. All releasing solutions contained (in mM): 100 KCl, 20 imidazole-
MOPS, pH 7.2, 1 mM ﬂuorescent Ca21 indicator and variable free
concentrations of Ca21 and Mg21. The procedures followed to calculate free
[Ca21] and [Mg21] and to determine the resulting free [Ca21] of releasing
solutions were described in detail previously (Donoso et al., 2000).
Other procedures
[3H]-Ryanodine binding was measured at pCa 5 as described (Bull et al.,
1989), except that we used lower ionic strength to compare Ryanodine
binding and release kinetics in similar conditions. The composition of the
solution was (in mM): 150 KCl, 0.5 AMP-PNP, 20 MOPS-Tris, pH 7.2, and
variable concentrations of free [Ca21] and [Mg21]. Total binding was
measured in the presence of 10 nM [3H]-Ryanodine (New England Nuclear,
Boston, MA). Nonspeciﬁc binding was measured in the presence of 10 nM
[3H]-Ryanodine plus 10 mM Ryanodine. Protein concentrations were
determined as described (Hartree, 1972), using commercial bovine serum
albumin as standard.
Materials
All reagents used were of analytical grade. Thimerosal, dithiothreitol, ATP,
AMP-PNP, Ryanodine, bovine serum albumin, and protease inhibitors
(Leupeptin, Pepstatin A, benzamidine, and phenylmethylsulfonyl ﬂuoride)
were obtained from Sigma Chemical Company (St. Louis, MO). All
ﬂuorescent calcium indicators were from Molecular Probes (Eugene, OR).
RESULTS
Ryanodine binding
The SR vesicles used in this study had a signiﬁcant density of
Ryanodine binding sites, with values ranging ;4 pmol per
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mg of protein when measured in 10 mM free [Ca21]. These
values are comparable to the highest values measured in
similar ionic conditions in cardiac microsomal SR prepara-
tions isolated with equivalent procedures to the one de-
scribed in this work (Xu et al., 1999; Yano et al., 2000; Doi
et al., 2002). [3H]-Ryanodine binding was negligible at free
[Ca21] \0.1 mM and exhibited a bell-shaped response to
Ca21, reaching the highest binding in a wide free [Ca21]
range, from 10 mM to 1 mM (Fig. 1, solid circles). Increasing
free [Ca21] to 10 mM led to 70% inhibition in [3H]-
Ryanodine binding. Addition of 0.8 mM free [Mg21]
decreased [3H]-Ryanodine binding at pCa 6 but did not
modify binding in the pCa range 5–2 (Fig. 1, open circles).
Active calcium accumulation and total
calcium released
Isolated cardiac SR vesicles (1 mg/ml) incubated in 50 mM
CaCl2 accumulated on average 41 6 2 nmol Ca
21 per mg
protein (mean 6 SD, n ¼ 5). Addition of 1.5 mM thapsi-
gargin produced complete inhibition of active Ca21 trans-
port; in contrast, 5 mM sodium azide had no effect. These
results indicate that active Ca21 uptake was carried out by
the cardiac SERCA2 pump and not by a mitochondrial
contaminant. Vesicles actively loaded in 100 mM CaCl2
increased their calcium load to 80 6 6 nmol/mg protein
(mean6 SD, n¼ 11). After cessation of calcium uptake with
no added CaCl2, or with 50 mM or 100 mM CaCl2, the
extravesicular free [Ca21] was 0.35 6 0.4 mM (mean 6 SE,
n ¼ 6). These results indicate that when loaded at 1 mg/ml
vesicles accumulated all the free [Ca21] present in the
extravesicular solution. In particular, these results indicate
that vesicles loaded with no added CaCl2 (9 mM free [Ca
21])
accumulated ;7 nmol/mg of protein (considering 2 nmol/
mg of nonspeciﬁc binding).
After dilution in releasing solutions, vesicles actively
loaded in the presence of 50 or 100 mM CaCl2 released, on
average, 50% of the total amount of calcium taken up.
Ca21 release kinetics
All release records followed exponential functions with rate
constants k. The release records obtained at pCa 6 or at pCa 5
followed double exponential functions, characterized by
a fast rate constant k1 and a slower rate constant k2, which
differed in magnitude by at least ﬁvefold (see below).
Accordingly, in these conditions we considered the higher
k1 values as an indication of the channel response to a sudden
[Ca21] change. In conditions that promoted very low release
activity, such as pCa $6.5 or pCa \5 or in the presence
of high free [Mg21] (see below), some release records
seemingly followed single exponential functions. Results
obtained at pCa 6 or at pCa 5 are detailed below.
pCa 6
The time courses of Ca21 release at pCa 6, collected at time
frames of 0.1, 0.5, and 5 s, are shown in Fig. 2. On average
(n ¼ 6) the initial fast exponential component, with k1 ¼
113 6 30 s1, was responsible for 50 6 16% of the total
ﬂuorescence change, whereas the second exponential
component, which accounted for the remaining 50%, had
a rate constant k2 ¼ 10.0 6 0.3 s1 (Fig. 2, A and B). In
about half the vesicular preparations, the double exponential
increase in ﬂuorescence with time observed at pCa 6 was
followed by a ﬂuorescence decrease, which was more
evident at longer times of data acquisition (Fig. 2 C). These
ﬁndings suggest that release channels closed after fast
activation by 1 mM [Ca21], allowing the Ca21 pump to
recapture the released Ca21 back into the SR.
We investigated next whether partial calcium depletion
from the vesicular lumen originated the double exponential
kinetic behavior of Ca21 release. For this purpose, we
compared release kinetics at pCa 6 from vesicles actively
loaded in solutions with different free [Ca21]. When
incubated in 50 mM, 100 mM, or with no CaCl2 added,
vesicles reached signiﬁcantly different luminal calcium
contents, as indicated above. Yet, in all three cases vesicles
exhibited double exponential Ca21 release kinetics (Fig. 3).
The values of k1 and k2 were 98 s1 and 7 s1, respectively,
for vesicles incubated in 100 mM CaCl2 (Fig. 3, upper
panel). The values of k1 and k2 were 111 s1 and 8.3 s1,
respectively, for vesicles incubated in 50 mM CaCl2 (Fig. 3,
middle panel). The ﬁrst release exponential obtained in
vesicles loaded either in 50 mM or in 100 mM CaCl2 tended
to zero in 40 ms, when the respective luminal calcium
contents were 27 nmol/mg or 55 nmol/mg protein (see
Discussion). Vesicles incubated with no added CaCl2
presumably attained much lower luminal calcium contents,
in the range of only 7 nmol/mg, and had values of k1 and k2
of 62 s1 and 4 s1, respectively (Fig. 3, lower panel). Yet
in all three cases the ﬁrst exponential ceased in \60 ms,
whereas the second exponential was virtually ended at 500
ms (Fig. 3 B). These results suggest strongly that a decrease
FIGURE 1 Calcium dependence of Ryanodine binding in cardiac SR
vesicles; speciﬁc [3H]-Ryanodine binding was determined by incubating
cardiac SR vesicles with 10 nM [3H]-Ryanodine in solutions containing the
indicated pCa and the compositions detailed in the text. (Solid circles)
control; (open circles) free [Mg21] ¼ 0.8 mM. Data represent mean 6 SE
from independent determinations in three different preparations.
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in luminal calcium content is not responsible for the double
exponential behavior of Ca21 release.
pCa 5
A double exponential increase in ﬂuorescence with time was
also evident at pCa 5. Fig. 4 A shows a 1 s record obtained at
pCa 5, with k1 ¼ 12.1 s1 and k2 ¼ 2.8 s1. On average (n
¼ 8), the initial fast exponential component had a rate
constant k1 ¼ 11 6 4 s1 and contributed 43.4 6 12.3% to
the total ﬂuorescence change, whereas the second exponen-
tial component had an average rate constant k2 ¼ 1.8 6 1.3
s1. In contrast to the behavior observed at pCa 6, the double
exponential increase in ﬂuorescence observed at pCa 5.0
was never followed by a ﬂuorescence decrease, even after
registering for times as long as 20 s. These results indicate
that channels activated at pCa 5 decreased their activity but
did not close completely after 20 s, in contrast to the behavior
observed at pCa 6. The 20 s Ca21 release record illustrated in
Fig. 4 B, obtained at pCa 5, shows a slower steady increase
in ﬂuorescence with a third rate constant of 0.06 s1. Such
low values of rate constants were not taken into account in
subsequent experiments.
FIGURE 3 Effect of intravesicular Ca21 load on Ca21 release kinetics.
Cardiac SR vesicles were actively loaded by incubation in solution with 100
mM CaCl2 (upper panel ), with 50 mM CaCl2 (middle panel ), or with no
added CaCl2 (lower panel ). Calcium release was induced at pCa 6 and 1.2
mM free ATP. Release records exhibited double exponential kinetics in all
cases, with rate constants k1 ¼ 98 s1 and k2 ¼ 7 s1 for vesicles incubated
in 100 mMCaCl2. The values were k1¼ 111 s1 and k2¼ 8.3 s1 for Ca21
release by vesicles incubated in 50 mM CaCl2, and k1 ¼ 62 s1 and k2 ¼
4.4 s1 for vesicles incubated in solution with no added CaCl2. Records
represent the average of six to eight determinations. The dashed lines
illustrate the corresponding theoretical ﬁrst and second exponential curves of
intravesicular calcium content decay (in %) with time, considering each
component contributed 50% to the total.
FIGURE 2 Calcium release kinetics determined at pCa 6. Cardiac SR
vesicles (1 mg/ml) actively loaded with calcium were mixed (1:10) in
a stopped ﬂow ﬂuorescence spectrometer with a solution designed to obtain
after mixing 1.2 mM free [ATP] and pCa 6, as detailed in the text. Calcium
release, measured as the change in ﬂuorescence of Calcium Green 5N,
followed a double exponential function. Values of k1 ¼ 110 s1 and k2 ¼
20 s1 were obtained in the 0.1 s record illustrated in A. Values of k1 ¼ 110
s1 and k2¼ 22 s1 were obtained from the 0.5 s record illustrated in B. (C)
Calcium release and recapture are shown in a record lasting 5 s. Records
represent the average of ﬁve to eight determinations.
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Calcium dependence of Ca21 release
A bell-shaped curve characterized the Ca21 dependence of
the release rate constants (Fig. 5A). The highest k1 value, 113
6 30 s1 (n¼ 6), was obtained at pCa 6; a marked decrease in
release rate constants was observed at lower or higher pCa
values. Thus k had an average value of 5.1 s1 at pCa 6.8 (n¼
2), whereas at pCa 4.8, the highest free [Ca21] that could be
reliably studied,kwas 15.4 s1 (n¼ 2). The bell-shaped curve
illustrated in Fig. 5 Awas generated by a combination of two
independent functions (Marengo et al., 1998), a cooperative
Ca21 activation function withKa¼ 0.6mMand na¼ 2.8, and
a cooperative Ca21 inactivation function, with Ki ¼ 0.9 mM
and ni¼ 1.6. In experiments where the ﬂuorescence followed
a double exponential increase, the rate constant of the slower
phase also showed a bell-shaped dependence on extravesic-
ular [Ca21], reaching its highest values at pCa 6 (data not
shown).
Effects of Mg21 on Ca21 release kinetics
Previous reports have shown that RyR2 channels are less
sensitive to Mg21 inhibition than skeletal RyR1 channels.
However, these results have been obtained by methods that
essentially represent equilibrium or steady-state measure-
ments, and studies on the effects of Mg21 in the time range
of physiological Ca21 release are lacking.
To investigate the effects of Mg21 on the calcium de-
pendence of release kinetics, we carried out experiments
in the presence of 1.2 mM free [ATP] plus 0.8 mM free
[Mg21] to approach physiological conditions. The results
illustrated in Fig. 5 B indicate that 0.8 mM free [Mg21] had
a marked effect on the calcium dependence of the release rate
constant. The maximal values of k1 obtained at pCa 6
decreased markedly, from 113 s1 to 13 s1, approaching k
values at pCa 5. It has been reported that Mg21 competes
effectively with Ca21 for the high afﬁnity activation sites of
both RyR1 and RyR2 channels when measured in steady
state conditions (Laver et al., 1997). The present kinetic
results support this report because 0.8 mM free [Mg21]
essentially abolished the strong stimulatory effect of 1 mM
free [Ca21] on release kinetics. Addition of Mg21 also
produced a shift to the right in the calcium-dependence
FIGURE 4 Calcium release kinetics determined at pCa 5. Cardiac SR
vesicles (1 mg/ml) actively loaded with calcium were mixed (1:10) in
a stopped ﬂow ﬂuorescence spectrometer with a solution designed to obtain,
after mixing, 1.2 mM free [ATP] and pCa 5, as stated under Methods.
Calcium release, measured as the change in ﬂuorescence of Calcium Green
5N with time, followed a double exponential function with k1 ¼ 12.1 s1
and k2 ¼ 2.8 s1 in the 1 s record illustrated in A. The longer ﬂuorescent
record illustrated in B exhibited a third rate constant of 0.06 s1 that
contributed in 3.2% to the total ﬂuorescence change illustrated in the record.
Records represent the average of ﬁve to eight determinations.
FIGURE 5 Calcium dependence of Ca21 release rate constants. Cardiac
SR vesicles (1 mg/ml) actively loaded with calcium were mixed (1:10) in
a stopped ﬂow ﬂuorescence spectrometer with solutions designed to obtain,
after mixing, 1.2 mM free [ATP] and the indicated pCa values. Fluo 3 was
used for determinations at pCa 6.8 and 6.5, Calcium Green 2 for pCa 6.3 and
6.2, and Calcium Green 5N for pCa #6. Release rate constants values were
obtained from Ca21 release records as described in the text as (A) in the
presence of nominally free (10 mM) [Mg21] or (B) in 0.8 mM free [Mg21].
Data represent Mean 6 SE from independent determinations in two to six
different preparations. The solid line through the data was obtained with the
equation k ¼ kmax/(11(Ka/[Ca21])na 1 ([Ca21]/Ki)ni). The best ﬁt
parameters for the curve shown in A were: kmax ¼ 300 s1, Ka ¼ 0.6
mM,Ki¼ 0.9 mM, na¼ 2.8, ni¼ 1.6. The best ﬁt parameters for the curve of
B were: kmax ¼ 300 s1, Ka ¼ 1.9 mM, Ki ¼ 0.25 mM, na ¼ 2, ni ¼ 1.
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curve; Ka increased from 0.6 mM to 1 mM and Ki from 0.9
mM to 2.6 mM. However, the signiﬁcant dispersion of the
experimental points precludes a more detailed analysis of
this shift.
To investigate the effects of varying free [Mg21] on
release kinetics, we carried out experiments at pCa 6 or pCa
5 while increasing free [Mg21] up to 0.8 mM. Further
increase in free [Mg21] was not feasible while maintaining
constant free [Ca21] and free [ATP].
The records illustrated in Fig. 6, A and B show that
increasing free [Mg21] from 10 mM to 300 mM in the
presence of 1.2 mM free [ATP] slowed down release kinetics
at pCa 6, reducing k1 to 40 s1, and k2 to 3.7 s1. The
experiment illustrated in Fig. 6 C shows a single exponential
record obtained in 0.8 mM [Mg21], with a rate constant k ¼
5.3 s1. Fig. 7 illustrates the decrease in k values caused by
increasing free [Mg21] from10mMto 0.8mM.Half-maximal
inhibition of k values was obtained at free [Mg21]¼ 636 28
mM, showing that increasing free [Mg21] strongly inhibited
RyR2 channels activated by 1 mM free [Ca21].
It is interesting to note that, even in 0.3 mM free [Mg21],
very fast Ca21 release could still be elicited at pCa 6 by
addition of 6 mM caffeine. Fig. 8 shows the double ex-
ponential release records obtained at pCa 6, 0.3 mM free
[Mg21], with or without 6 mM caffeine. Caffeine addition
increased k1 from 30 s1 to 83 s1, and k2 from 0.2 s1 to
4.3 s1. The k1 value obtained in 0.3 mM free [Mg21] plus
6 mM caffeine, 83 s1, is comparable within experimental
error to the k1 values of 113 6 30 s1 obtained at pCa 6 in
the absence of Mg21 (see Fig. 7). Thus caffeine was able to
overcome the strong inhibition exerted by Mg21 on RyR2
channels activated by 1 mM free [Ca21].
At pCa 5 and in the free [Mg21] range from 10 mM up to
0.8 mM, all preparations displayed Ca21 release time
courses that followed a double exponential function. In
contrast to the results obtained at pCa 6, increasing free
[Mg21] up to 0.8 mM had little effect at pCa 5 on the values
of the faster rate constants k1 (Fig. 7) or k2 (data not shown).
These results are in agreement with previous reports in-
dicating that at pCa 5 Mg21 mostly binds to the low afﬁ-
nity inhibitory site of RyR2 channels without interfering
with the Ca21 activation site that at pCa 5 is saturated with
Ca21 (Laver et al., 1997).
FIGURE 6 Effect of [Mg21] on Ca21 release kinetics. Calcium release
was induced by mixing 1 volume of actively loaded cardiac SR vesicles with
10 volumes of releasing solutions designed to obtain, after mixing, 1.2 mM
free [ATP] and various [Mg21] at pCa 6. (A) Calcium release in 13.6 mM
[Mg21] exhibited rate constants of 111 s1 and 14.5 s1. The inset shows the
initial 50 ms of Ca21 release. (B) Calcium release in 305 mM [Mg21]
exhibited rate constants of 40 s1 and 3.7 s1. The inset shows the initial 50
ms of Ca21 release. (C) Calcium release in 0.8 mM [Mg21] followed a single
exponential increase in ﬂuorescence with a rate constant of 5.3 s1. Records
represent the average of six to eight determinations.
FIGURE 7 Mg21 inhibition of Ca21 release rate constants at pCa 6 and
pCa 5. Rate constants of Ca21 release of the faster exponential obtained in
the presence of different [Mg21] were calculated from ﬂuorescence records
such as the records shown in Fig. 6. Data represent Mean 6 SE from
independent determinations in three to seven different preparations.
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Effects of thimerosal on Ca21 release kinetics
Thimerosal, which presumably affects the redox state of
RyR2 channels through reaction with free sulfhydryl
residues, signiﬁcantly enhances Ca21 activation of single
RyR2 channels in the absence of Mg21 (Marengo et al,
1998) and diminishes the inhibitory effects of Mg21 on
release kinetics in skeletal SR (Donoso et al., 2000). To
investigate the effects of thimerosal on RyR2-mediated
calcium release, we measured release kinetics at pCa 6 or 5 at
different free [Mg21].
pCa 6
Incubation of cardiac SR vesicles with thimerosal did not
modify release kinetics at pCa 6 when measured in free
[Mg21]\100 mM, yielding k values undistinguishable from
those obtained in control vesicles (Fig. 9). However, we
observed a modest stimulation of release kinetics at higher
free [Mg21], reﬂected in an increase in k values when
compared to controls (Fig. 9). Incubation with thimerosal
increased twofold the K0.5 for Mg
21 inhibition of k values,
from 63 6 28 mM to 136 6 34 mM. These results suggest
that thimerosal, presumably through oxidation, diminishes
the strong inhibitory effect of Mg21 on channel activation by
1 mM [Ca21].
pCa 5
On average, vesicles incubated with thimerosal displayed at
pCa 5 and in the absence of Mg21 higher rate constants of
Ca21 release, 34.9 6 6.3 s1 (n ¼ 3), than control vesicles.
Furthermore, incubation of vesicles with thimerosal pro-
duced an increase in the release rate constant k1 over the
whole range of Mg21 concentrations tested, with no signs of
inhibition (Fig. 9).
We also found that the effect of thimerosal was reversible
provided the time of exposure to thimerosal was limited. Fig.
10 illustrates an experiment where native channels dis-
played, at pCa 5, a k1 value of 12 s1. After incubation of
vesicles for 5 min with 0.25 mM thimerosal, k1 increased to
29 s1. A second 5 min incubation with 5 mM dithiothreitol
produced a marked decrease in k1, to a value of 7 s1. These
results show that reducing agents not only reversed the
activation of release kinetics by thimerosal but also produced
a strong inhibition of CICR. Similar inhibition of RyR2
channels by reducing agents has been described in single
channel experiments (Marengo et al., 1998).
DISCUSSION
Ryanodine binding studies and determinations of the activity
of single channels incorporated in lipid bilayers have been
the methods most commonly used to characterize the Ca21
dependence of RyR2 channels. These methods, however, are
not equivalent to the determination of fast Ca21 release
ﬂuxes in isolated vesicles because they measure the response
of the channels in slower time frames. Ryanodine binding
measurements are done at equilibrium, and steady-state
conditions are used most often to characterize the activity of
single channels. However, steady-state measurements may
not reveal all the aspects of cellular channel regulation
FIGURE 9 Effect of Mg21 on Ca21 release rate constants in oxidized
vesicles. Cardiac SR vesicles actively loaded with Ca21were incubated for 5
min with 250 mM thimerosal and release was induced at different [Mg21]
and 1.2 mM free [ATP] at pCa 5 and 6. Release rate constant values were
obtained from Ca21 release records as described in the text. Data represent
Mean 6 SE from independent determinations in three to ﬁve different
preparations.
FIGURE 8 Effect of Caffeine on Ca21 release kinetics in the presence of
Mg21. Calcium release was induced by mixing 1 volume of actively loaded
cardiac SR vesicles with 10 volumes of a releasing solution designed to
obtain, after mixing, 1.2 mM free [ATP] and 305 mM [Mg21] at pCa 6.
Releasing solutions had no caffeine (lower record) or contained 6 mM
caffeine (upper record). Release rate constants in the absence of caffeine
were k1 ¼ 30 s1 and k2 ¼ 0.2 s1. After addition of 6 mM caffeine the
values of release rate constants were k1¼ 83 s1 and k2 ¼ 4.3 s1. Records
represent the average of six to eight determinations.
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because RyR2 channels function in a dynamic calcium
signaling environment where cytoplasmic free [Ca21] in-
creases and decreases in the ms time scale. Determinations of
fast Ca21 release kinetics provide information on how
a channel population responds in the ms temporal scale to
changes in the composition of the extravesicular solution.
Accordingly, we used this technique to investigate how
Ca21, Mg21 and channel redox state inﬂuence release
kinetics from SR vesicles isolated from cardiac muscle. The
results obtained suggest that RyR2 channel-mediated release
is subject to two different types of regulation: fast regulation
of channel activity by Ca21 and Mg21, followed by time-
dependent regulation, which is also modulated by Ca21 and
Mg21. We will analyze time-dependent regulation ﬁrst.
Time-dependent changes in Ca21 release ﬂuxes
At pCa 6 or 5, all release records followed double
exponential functions. In all cases, the ﬁrst exponential
contributed ;50% to total calcium release. This behavior is
not a consequence of inhibition of channel activity by an
extravesicular [Ca21] increase. All releasing solutions
contained 1.2 mM free ATP, which, in our experimental
conditions, limited the total increase in free [Ca21] to less
than 0.3 mM. (Please note that the ﬁnal protein concentration
in all release experiments was 90 mg per ml. Vesicles
actively loaded with 100 mM [Ca21], the highest concen-
tration used, had released 27 nmol/mg of protein after the
completion of the ﬁrst exponential; see Fig. 11. This release
would cause an increase in total extravesicular [Ca21] of
only 2.4 nmol/ml. Inasmuch as all releasing solutions
contained 1.2 mM free [ATP], the calculated increase in
free [Ca21] was \0.3 mM.) We can also dismiss the
combined presence, in equal proportions, of vesicles
containing channels highly activated by Ca21 with vesicles
containing less responsive channels as the source of the
double exponential release kinetics. Cardiac SR vesicles
contain only RyR2 channels, and it is very unlikely that all
preparations contained exactly one-half each channel kind.
A decrease in luminal (trans) [Ca21] inhibits calcium
release mediated by skeletal RyR1 channels (Donoso et al.,
1995) and the activity of single RyR2 channels in bilayers
(Sitsapesan and Williams, 1995). Accordingly, to investigate
if the double exponential behavior was caused by luminal
calcium decrease, we measured Ca21 release kinetics at pCa
6 in vesicles with different calcium contents. Vesicles loaded
with no added CaCl2, which at most attained total luminal
calcium contents of 7 nmol/mg of protein, had by 60 ms
completed the ﬁrst exponential, which exhibited a reduced
k1 value (two-thirds) when compared to vesicles loaded at
higher [CaCl2]. The lower intravesicular calcium content
attained by these vesicles could account for this reduction in
k1. Vesicles actively loaded in 50 mM or 100 mM [Ca21],
which attained much higher calcium contents, exhibited ﬁrst
exponential components that ceased by 40 ms (Fig. 3).
Theoretical simulations give intravesicular calcium contents
of 27 nmol/mg or 55 nmol/mg of protein, respectively, at this
time (Fig. 11 A). Hence, we can rule out luminal calcium
decrease as the cause of the double exponential behavior,
because release kinetics changed even in vesicles that
contained signiﬁcant luminal calcium. We can extrapolate
this conclusion to experiments done at pCa 5, or at different
pCa values and varying free [Mg21], because in all cases the
ﬁrst exponential ceased when vesicles contained signiﬁcant
luminal calcium contents.
We propose that a time-dependent decrease in RyR2
channel open probability as the most likely explanation for
the double exponential kinetic behavior of release ﬂuxes.
Single RyR2 channels display spontaneous changes in
channel activity, a process known as modal gating. Periods
of high open probability (H-mode) alternate with periods of
low (L-mode) or no activity (I-mode) (Zahradnı´kova´ and
Zahradnı´k, 1995, 1996; Armise´n et al., 1996). Modal gating
could account for the phenomenon of adaptation exhibited
by RyR2 channels in bilayers in response to a step increase
in [Ca21] generated by ﬂash photolysis of DM-nitrofen
(Gyo¨rke and Fill, 1993; Valdivia et al., 1995). After a fast
FIGURE 10 Reversibility of the effects of thimerosal. Calcium release
was induced at pCa 5, 1.2 mM free ATP, 0.8 mM free [Mg21]. (A) Native
cardiac SR vesicles. (B) Vesicles incubated with 250 mM thimerosal for
5 min. (C) Vesicles incubated with 250 mM thimerosal for 5 min and then
for 5 min with 5 mM dithiothreitol.
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increase in free [Ca21], channels would open ﬁrst in the
H-mode and would adopt at later times the L-mode to reach
equilibrium between both modes in the steady state
(Zahradnı´kova´ et al., 1999). Our ﬁndings are compatible
with an adaptation process. Furthermore, channel experi-
ments in bilayers indicate that Mg21 accelerates channel
adaptation after a step increase in [Ca21] from 0.1 mM to 1 or
10 mM (Valdivia et al., 1995). We found that increasing free
[Mg21] caused a progressive decrease in the rate constant of
the ﬁrst release exponential at pCa 6 but not at pCa 5 (see
below). These results suggest that at pCa 6 increasing free
[Mg21] would accelerate the conversion of channels from
a high to a lower open probability mode. However,
adaptation has been questioned (Sitsapesan et al., 1995;
Lamb et al., 2000) and other reports are consistent with
inactivation rather than adaptation of Ca21 release channels.
Inactivation of RyR2 channels, which is responsible for
termination of Ca21 release in isolated cardiac myocytes
(Sham et al., 1998), would also explain our results.
Furthermore, Ca21 release ﬂuxes, mediated either by skeletal
RyR1 channels or by IP3 receptor channels, exhibit double
exponential kinetics (Champeil et al., 1989; Me´sza´ros et al.,
1998). To explain this behavior, a model based on the
tetrameric structure of the channels was proposed whereby
channels would open regardless of how many sites of the
activating ligand (Ca21) are occupied, but the tendency to
inactivate would be higher at lower occupancy (Me´sza´ros
et al., 1998). In principle, this model would explain why at
lower activating [Ca21] (pCa 6), but not at higher [Ca21]
(pCa 5), RyR2 channels closed completely after activation.
Calcium dependence of fast Ca21 release ﬂuxes
The calcium dependence of the fast release rate constants
represents the immediate response of RyR2 channels to
a sudden free [Ca21] increase. We found that in 1.2 mM free
[ATP] and in the absence of [Mg21], the Ca21 dependence
of release rate constants followed a bell-shaped curve, with
maximal k values in the order of 110 s1 at pCa 6. This bell-
shaped curve can be generated by a combination of two
independent functions, a Ca21 activation function and a Ca21
inactivation function (Marengo et al, 1998). A more detailed
analysis of these two functions is given below, when
discussing the effects of Mg21 on Ca21 release ﬂuxes.
Release rate constants increased 20-fold when raising free
[Ca21] from pCa 6.8 to pCa 6, showing that even in 1.2 mM
[ATP], RyR2 channels show Ca21-dependent activation. A
similar Ca21-dependent increase in rate constants in the pre-
sence of b,g-methyleneadenosine-59-trisphosphate has been
reported previously for cardiac SR vesicles (Meissner and
Henderson, 1987). These results show conclusively that ATP
by itself is not sufﬁcient for maximal activation of RyR2
channels. Increasing free [Ca21] beyond 1 mM caused a
marked decrease in channel activity. The present ﬁndings
differ from previous reports indicating that, in the absence of
Mg21, RyR2 channels remain maximally activated even at
pCa\4 (Laver et al., 1995; Xu et al., 1996; Liu et al., 1998;
Marengo et al., 1998; Fruen et al., 2000). A similar discre-
pancy between results obtained using different methodolo-
gies was reported by Chu et al. (1993), who found that Ca21
release from cardiac vesicles was inhibited atmM free [Ca21]
whereas RyR2 channels in bilayers were not. We interpret
these results as an indication that RyR2 channels respond
differently when activated by a sudden increase in free
[Ca21] than when exposed to the same [Ca21] for longer
periods, as in Ryanodine binding experiments. It is worth
noting in this regard that the rate of calcium release in skinned
cardiac Purkinje ﬁbers depends not only on trigger [Ca21]
but also on the time taken to reach trigger [Ca21] (Fabiato,
1985). A model was proposed whereby RyR2 channels
FIGURE 11 (A) Theoretical curves depicting the variation in luminal
calcium content as a function of time. A function representing the sum of
two exponential decay functions (N ¼ N1 exp(k1 t) 1 N2 exp(k2 t) 1
basal) was generated. The following parameters correspond to vesicles
actively loaded in 100 mM CaCl2 (curve 1) or in 50 mM CaCl2 (curve 2).
(Curve 1) k1¼ 98 s1, k2¼ 7 s1,N1¼N2¼ 20 nmol/mg protein, basal¼
40 nmol/mg protein. (Curve 2) k1 ¼ 110 s1, k2 ¼ 10 s1, N1 ¼ N2 ¼
10 nmol/mg protein, basal 20.5 nmol/mg protein. (B) Theoretical calcium-
dependence curves of calcium release rate constants. The bell-shaped curves
(solid lines) correspond to the calcium dependencies of k measured in the
absence or in the presence of 0.8 mM free [Mg21] shown in Fig. 5, A and B.
(Dotted lines) Illustrate the individual activation and inactivation functions
generated in the absence of [Mg21]. (Dashed lines) The functions
corresponding to 0.8 mM [Mg21]. For further details, see article text and
Fig. 5 legend.
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inactivation sites bind Ca21 with higher afﬁnity but with
lower association rates than activating sites (Fabiato, 1985).
This model would explain why methods with different time
resolution yield different results. After fast calcium activa-
tion, channels would initially display high activity, switching
to lower activity after calcium binding to inhibitory sites.
Only the lower activity mode would remain in steady-state
conditions. This model may explain as well the observed
time-dependent changes in channel activity discussed above.
A comparison of the calcium-dependence curve of rate
constants obtained in cardiac SR vesicles (Fig. 5 A) with the
calcium dependence of skeletal SR vesicles (Donoso et al.,
2000) shows signiﬁcant differences. Maximal activation of k
was observed at pCa 5 in skeletal SR, whereas cardiac SR
displayed maximal activation at pCa 6. Cardiac SR vesicles
presented signiﬁcant reduction in k values at pCa 5, whereas
only at pCa 4 skeletal SR vesicles show a signiﬁcant
decrease in k. This comparison suggests that, if the present
results reﬂected the physiological response of RyR2
channels, Ca21 activation of Ca21 release in cardiac muscle
would be most efﬁcient in 1 mM free [Ca21]. However, Ca21
release in vivo occurs in the presence of 0.7–1 mM free
[Mg21]. Accordingly, to have a better approximation to the
physiological situation, it was necessary to measure CICR
kinetics mediated by RyR2 channels in the presence of
physiological free Mg21 concentrations.
Effects of Mg21 on Ca21 release ﬂuxes
Ryanodine-binding experiments and determinations of
single channel activity in planar lipid bilayers indicate that
cardiac RyR2 channels are less sensitive to inhibition by
Mg21 than their skeletal muscle counterparts (Meissner and
Henderson, 1987; Chu et al., 1993; Laver et al., 1997).
Presumably, this lower sensitivity to Mg21 inhibition allows
CICR to operate efﬁciently in the heart but not in mammalian
skeletal muscle (Lamb and Laver, 1998, Lamb, 2000). In
native vesicles we found that Mg21 was a very effective
inhibitor of Ca21 release at pCa 6, with K0.5\100 mM. The
present K0.5 values agree with reported mM Ki values for
Mg21 inhibition of channel open probability at pCa 6 and 5
mM ATP (Kawano, 1998). In contrast, even 0.8 mM free
[Mg21] had no effect at pCa 5. These results agree with other
reports showing that at free [Ca21][15 mM, free [Mg21]
\1 mM does not inhibit RyR2 channel open probability or
[3H]-Ryanodine binding to isolated cardiac SR vesicles (Xu
et al., 1996; Laver et al., 1997). Our data support the
proposal that Mg21 and Ca21 compete for channel activation
sites at pCa 6, whereas at pCa 5Mg21 does not bind to Ca21-
saturated activation sites (Laver et al., 1997).
Additionally, we found that although the calcium de-
pendence of release rate constants changed signiﬁcantly by
addition of 0.8 mM free [Mg21] (Fig. 5 B), Ryanodine
binding was much less affected (Fig. 1). These results show
once again that RyR2 channels respond differently to
activation by a sudden increase in free [Ca21] than when
exposed to the same [Ca21] for a sustained period. As
discussed above, the bell-shaped calcium-dependence curve
can be generated by a combination of two independent
functions, a Ca21 activation function and a Ca21 inactivation
function (Marengo et al., 1998).We have constructed amodel
assuming that Mg21 competes with Ca21 for the high afﬁnity
channel activation sites (Laver et al., 1997) and shifts to the
right the activation function. We propose, in addition, that
increasing free [Mg21] progressively enhances channel
inactivation by Ca21 and effectively shifts to the left the
inactivation function. Thus, by increasing Ka from 0.6 mM to
1.9mManddecreasingKi from 0.9mMto 0.25mMthismodel
can generate the calcium-dependence curve obtained exper-
imentally in the presence of 0.8 mM free [Mg21]. A
comparison of the individual activation and inactivation
functions and the resulting calcium-dependence curves is
illustrated in Fig. 11 B. In the absence of Mg21, this
theoretical model predicts maximal activation of release rate
constants at pCa 6, due to the relative predominance of the
activation over the inactivation function. Likewise, in the
presence ofMg21 themodel predicts the observed decrease in
k values at pCa 6, due to the predominance of the inactivation
over the activation function. In contrast, regardless of the
presence of Mg21, at pCa 5 both functions would have at-
tained their maximal values, yielding signiﬁcantly decreased
yet similar k values at pCa 5. This model accounts well for the
experimentally observed lack of inhibition byMg21 at pCa 5.
According to this model, caffeine would shift markedly to the
left the activation function allowing high release rates even in
the presence of 0.3 mM free [Mg21] (Fig. 8).
It is important to point out that the model described in this
work is conceptually different from the model proposed
by Fabiato (1985), according to which RyR2 channels in-
activation sites bind Ca21 with higher afﬁnity but with lower
association rates than activating sites. In contrast, the model
we propose postulates that RyR2 channels have calcium
activation and inhibitions sites with equally fast binding
kinetics.
Effect of thimerosal on Ca21 release ﬂuxes
The redox status of the channel protein affects RyR channel
activity, as determined with different experimental ap-
proaches. Changes in redox state of RyR channels from
skeletal or cardiac muscle modiﬁes the open probability of
single channels in planar bilayers (Abramson et al., 1995;
Favero et al., 1995; Eager et al., 1997; Marengo et al., 1998),
as well as Ryanodine binding (Abramson et al., 1995; Favero
et al., 1995; Aghdasi et al., 1997; Suko and Hellman, 1998).
Changes in redox state also affect Ca21 release from cardiac
SR vesicles (Prabhu and Salama, 1990).
We found that incubation of RyR2 channels with
thimerosal—that presumably alkylates free sulfhydryl resi-
dues of the RyR2 protein—did not modify release rate
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constants at pCa 6 in the absence of Mg21. These results
suggest that the sites of the RyR2 channel protein involved in
high afﬁnity Ca21 activation lack thimerosal-responsive
sulfhydryl groups. However, thimerosal reduced the inhib-
itory effect of 0.8 mM free [Mg21] at pCa 6. Likewise, at
pCa 5 thimerosal induced a threefold increase in release rate
constants either in the absence or in the presence of up to 0.8
mM free [Mg21] (Figs. 7 and 9). In this regard, release
through RyR2 channels behaves as release through skeletal
RyR1 channels, which even in the presence of 1 mM free
[Mg21] is signiﬁcantly activated by thimerosal at pCa 5
(Donoso et al., 2000). We propose that modiﬁcation of free
sulfhydryl residues present in Ca21/Mg21 inhibitory site(s)
of the cardiac RyR2 channels would decrease the afﬁnity of
the site for both Ca21 and Mg21. In terms of our model (Fig.
11 B), we propose that thimerosal reduces the left shift of the
inactivation function induced by Mg21.
Taken together, these results suggest that oxidation of
RyR2 channels would produce signiﬁcant enhancement of
CICR in vivo. Redox modulation of RyR2 channels could be
a physiologically relevant mechanism in the heart, especially
in circumstances where there is an increase in free radical
production, as in ischemia/reperfusion situations (Ambrosio
and Tritto, 1999; Menshikova and Salama, 2000).
Physiological implications
ATP in mM concentrations is a well-known endogenous
activator of RyR channels. Accordingly, in an attempt to
approach the conditions present in the cytoplasm of heart
cells, all kinetic experiments described in this study were
done in the presence of 1.2 mM ATP. In such conditions,
Mg21 was an effective inhibitor of CICR at pCa 6, with K0.5
\100 mM, but not at pCa 5. We explain this preferential
inhibition by Mg21 with a model that proposes fast binding
of Ca21 and Mg21 to independent activation and inhibition
sites of the RyR2 channel protein. In the presence of 0.8 mM
[Mg21] release rate constants at pCa 6 were comparable to
those obtained at pCa 5, although in both cases the ﬁrst
exponential component of calcium release ceased when
vesicles still contained signiﬁcant luminal calcium. These
results suggest that under physiological conditions a sudden
increase in cytoplasmic [Ca21], from its resting level to
1 mM or 10 mM, would sufﬁce to activate RyR2 channels
maximally, although transiently. According to the present
results, after activation by a sudden free [Ca12] increase,
RyR2 channels would change with time from a high activity
to a low activity mode. We propose that this response is
a reﬂection of an intrinsic time-dependent change in RyR2
channel open probability. Assuming our results from release
experiments in vitro reﬂect the behavior of cardiac Ca21
release channels in vivo, we propose that a time-dependent
decrease in channel activity after activation by Ca21 might
facilitate channel closure during each cardiac contraction/
relaxation cycle.
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